Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
US Stock MarketDetailed Quotes
VNT Vontier
- 31.290
- +1.060+3.51%
Close Apr 24 16:00 ET
- 31.290
- 0.0000.00%
Post 16:05 ET
4.64BMarket Cap11.38P/E (TTM)
31.370High30.185Low912.75KVolume30.230Open30.230Pre Close28.39MTurnover0.62%Turnover Ratio11.38P/E (Static)148.32MShares41.61552wk High4.42P/B4.62BFloat Cap27.22052wk Low0.10Dividend TTM147.51MShs Float45.494Historical High0.32%Div YieldTTM3.92%Amplitude16.418Historical Low31.108Avg Price1Lot Size
Vontier Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 27, 2024 | (Q2)Jun 28, 2024 | (Q1)Mar 29, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 29, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -6.04%427.5M | 1.94%168.1M | -7.45%121.8M | -40.52%46.1M | 12.96%91.5M | 41.66%455M | -9.10%164.9M | 44.14%131.6M | 976.39%77.5M | 96.13%81M |
| Net income from continuing operations | 12.02%422.2M | 16.29%123.5M | 1.32%91.8M | -27.95%70.1M | 65.22%136.8M | -6.08%376.9M | 56.87%106.2M | 80.84%90.6M | 192.19%97.3M | -66.91%82.8M |
| Operating gains losses | -8.14%-37.2M | --0 | --0 | --2.6M | ---39.8M | -5.20%-34.4M | --0 | 89.29%-300K | ---- | ---- |
| Depreciation and amortization | 1.68%127.1M | 4.49%32.6M | 2.89%32M | -1.58%31.1M | 0.96%31.4M | 5.13%125M | -2.80%31.2M | 8.36%31.1M | 8.97%31.6M | 6.87%31.1M |
| Other non cash items | -2.94%3.3M | -270.00%-1.7M | -18.18%900K | 81.25%2.9M | 500.00%1.2M | -71.43%3.4M | -89.36%1M | 37.50%1.1M | 100.00%1.6M | -133.33%-300K |
| Change In working capital | -152.11%-119.5M | -61.26%7.4M | -3,700.00%-10.8M | -150.00%-68.5M | -20.81%-47.6M | 77.56%-47.4M | -52.37%19.1M | 100.51%300K | 80.83%-27.4M | 20.08%-39.4M |
| -Change in receivables | -711.59%-56M | -136.70%-9.8M | 31.93%-30.7M | 141.50%12.7M | -166.98%-28.2M | 91.03%-6.9M | 3,437.50%26.7M | -1.81%-45.1M | 53.28%-30.6M | 24.93%42.1M |
| -Change in inventory | -199.18%-48.5M | ---- | ---- | ---- | ---- | 165.81%48.9M | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | 122.31%14.9M | ---- | ---- | ---- | ---- | -413.62%-66.8M | ---- | ---- | ---- | ---- |
| -Change in other working capital | -32.30%-29.9M | 393.20%50.8M | -56.17%19.9M | -2,637.50%-81.2M | 76.20%-19.4M | 72.20%-22.6M | -89.03%10.3M | 406.76%45.4M | 104.13%3.2M | 1.81%-81.5M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -6.04%427.5M | 1.94%168.1M | -7.45%121.8M | -40.52%46.1M | 12.96%91.5M | 41.66%455M | -9.10%164.9M | 44.14%131.6M | 976.39%77.5M | 96.13%81M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -116.45%-11.4M | 1.80%-16.4M | -8.00%-18.9M | -128.68%-27.1M | 466.67%51M | 121.01%69.3M | -339.47%-16.7M | 83.47%-17.5M | 662.50%94.5M | 104.42%9M |
| Net PPE purchase and sale | -38.67%-77.1M | 3.66%-15.8M | -5.17%-18.3M | -92.68%-23.7M | -103.16%-19.3M | 6.71%-55.6M | 2.38%-16.4M | -5.45%-17.4M | 9.56%-12.3M | 25.20%-9.5M |
| Net business purchase and sale | -37.32%65.5M | 3.33%-2.9M | -42.31%1.5M | -103.18%-3.4M | 3,800.00%70.3M | 136.12%104.5M | 75.41%-3M | 103.13%2.6M | 3,437.50%106.8M | 99.00%-1.9M |
| Net investment purchase and sale | -99.02%200K | -14.81%2.3M | 22.22%-2.1M | --0 | --0 | 7.37%20.4M | -89.29%2.7M | 56.45%-2.7M | --0 | --20.4M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -116.45%-11.4M | 1.80%-16.4M | -8.00%-18.9M | -128.68%-27.1M | 466.67%51M | 121.01%69.3M | -339.47%-16.7M | 83.47%-17.5M | 662.50%94.5M | 104.42%9M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -1.16%-392.3M | -55.03%-115.5M | -20.51%-109.3M | 31.24%-93.1M | 14.68%-74.4M | -11.47%-387.8M | 24.75%-74.5M | -752.52%-90.7M | -17,025.00%-135.4M | 66.92%-87.2M |
| Net issuance payments of debt | 48.17%-154.5M | 10.42%-53.3M | 99.87%-100K | 49.95%-50.1M | 16.53%-51M | -74,625.00%-298.1M | -11.84%-59.5M | -323.70%-77.4M | -638.17%-100.1M | -15,375.00%-61.1M |
| Net common stock issuance | -200.80%-224.7M | -358.78%-60.1M | -804.31%-104.9M | -19.44%-38.1M | -19.34%-21.6M | 77.23%-74.7M | 67.25%-13.1M | 31.36%-11.6M | -126.24%-31.9M | 92.96%-18.1M |
| Cash dividends paid | 1.94%-15.2M | 2.63%-3.7M | 2.56%-3.8M | 2.56%-3.8M | 0.00%-3.9M | 2.52%-15.5M | 2.56%-3.8M | 2.50%-3.9M | 2.50%-3.9M | 2.50%-3.9M |
| Proceeds from stock option exercised by employees | 63.46%17M | -40.91%2.6M | -75.86%700K | -52.63%900K | 966.67%12.8M | 316.00%10.4M | 266.67%4.4M | 314.29%2.9M | 216.67%1.9M | --1.2M |
| Net other financing activities | -50.51%-14.9M | 60.00%-1M | -71.43%-1.2M | -42.86%-2M | -101.89%-10.7M | -43.48%-9.9M | 19.35%-2.5M | -40.00%-700K | -366.67%-1.4M | -76.67%-5.3M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -1.16%-392.3M | -55.03%-115.5M | -20.51%-109.3M | 31.24%-93.1M | 14.68%-74.4M | -11.47%-387.8M | 24.75%-74.5M | -752.52%-90.7M | -17,025.00%-135.4M | 66.92%-87.2M |
| Net cash flow | ||||||||||
| Beginning cash position | 66.70%340.9M | 25.53%330.9M | 35.78%331.3M | 95.00%406M | 66.70%340.9M | -64.29%204.5M | 116.60%263.6M | 91.52%244M | 43.49%208.2M | -64.29%204.5M |
| Current changes in cash | -82.56%23.8M | -50.88%36.2M | -127.35%-6.4M | -302.46%-74.1M | 2,332.14%68.1M | 138.28%136.5M | -6.23%73.7M | 3,442.86%23.4M | 515.91%36.6M | 100.66%2.8M |
| Effect of exchange rate changes | -8,200.00%-8.3M | -397.22%-10.7M | 257.89%6M | 25.00%-600K | -433.33%-3M | 99.13%-100K | -14.29%3.6M | 24.00%-3.8M | 91.01%-800K | 150.00%900K |
| End cash Position | 4.55%356.4M | 4.55%356.4M | 25.53%330.9M | 35.78%331.3M | 95.00%406M | 66.70%340.9M | 66.70%340.9M | 116.60%263.6M | 91.52%244M | 43.49%208.2M |
| Free cash flow | -12.69%344.8M | -0.20%148M | -9.63%103.2M | -65.75%22.3M | 5.94%71.3M | 51.19%394.9M | -9.79%148.3M | 52.67%114.2M | 1,117.19%65.1M | 136.97%67.3M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call